Pathophysiology, diagnosis, and management of endometriosis
AW Horne, SA Missmer - bmj, 2022 - bmj.com
Endometriosis affects approximately 190 million women and people assigned female at birth
worldwide. It is a chronic, inflammatory, gynecologic disease marked by the presence of …
worldwide. It is a chronic, inflammatory, gynecologic disease marked by the presence of …
Rethinking mechanisms, diagnosis and management of endometriosis
C Chapron, L Marcellin, B Borghese… - Nature Reviews …, 2019 - nature.com
Endometriosis is a chronic inflammatory disease defined as the presence of endometrial
tissue outside the uterus, which causes pelvic pain and infertility. This disease should be …
tissue outside the uterus, which causes pelvic pain and infertility. This disease should be …
Treatment of endometriosis: a review with comparison of 8 guidelines
DR Kalaitzopoulos, N Samartzis, GN Kolovos… - BMC women's …, 2021 - Springer
Background Endometriosis, the presence of endometrial-like tissue outside the uterus, is a
common clinical entity between women of reproductive age, with a prevalence of about …
common clinical entity between women of reproductive age, with a prevalence of about …
[HTML][HTML] Clinical diagnosis of endometriosis: a call to action
SK Agarwal, C Chapron, LC Giudice, MR Laufer… - American journal of …, 2019 - Elsevier
Endometriosis can have a profound impact on women's lives, including associated pain,
infertility, decreased quality of life, and interference with daily life, relationships, and …
infertility, decreased quality of life, and interference with daily life, relationships, and …
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies …
LC Giudice, S As-Sanie, JCA Ferreira, CM Becker… - The Lancet, 2022 - thelancet.com
Background Endometriosis is a common cause of pelvic pain in women, for which current
treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone …
treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone …
The burden of endometriosis on women's lifespan: a narrative overview on quality of life and psychosocial wellbeing
L Della Corte, C Di Filippo, O Gabrielli… - International journal of …, 2020 - mdpi.com
Endometriosis is a chronic, inflammatory disease affecting more than 170 million women
worldwide and up to 10% of women of reproductive age. As a consequence of inflammatory …
worldwide and up to 10% of women of reproductive age. As a consequence of inflammatory …
[HTML][HTML] Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment
E Rolla - F1000Research, 2019 - ncbi.nlm.nih.gov
Endometriosis is an enigmatic disease that could start at birth. Its pathogenesis is supported
by different theories. Accumulating facts relate it to a multigenic disorder. In this review of …
by different theories. Accumulating facts relate it to a multigenic disorder. In this review of …
World Endometriosis Society consensus on the classification of endometriosis
STUDY QUESTION What is the global consensus on the classification of endometriosis that
considers the views of women with endometriosis? SUMMARY ANSWER We have …
considers the views of women with endometriosis? SUMMARY ANSWER We have …
Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus …
S Guerriero, G Condous… - … in Obstetrics & …, 2016 - Wiley Online Library
ABSTRACT The IDEA (International Deep Endometriosis Analysis group) statement is a
consensus opinion on terms, definitions and measurements that may be used to describe …
consensus opinion on terms, definitions and measurements that may be used to describe …
Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist
HS Taylor, LC Giudice, BA Lessey… - … England Journal of …, 2017 - Mass Medical Soc
Background Endometriosis is a chronic, estrogen-dependent condition that causes
dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing …
dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing …